Lang Thomas, Haberl Michael, Jung Diana, Drescher Anja, Schlagenhaufer Robert, Keil Andrea, Mornhinweg Esther, Stieger Bruno, Kullak-Ublick Gerd A, Kerb Reinhold
EPIDAUROS Biotechnologie AG, Bernried, Germany.
Drug Metab Dispos. 2006 Sep;34(9):1582-99. doi: 10.1124/dmd.105.008854. Epub 2006 Jun 8.
Biliary excretion of bile salts and other bile constituents from hepatocytes is mediated by the apical (canalicular) transporters P-glycoprotein 3 (MDR3, ABCB4) and the bile salt export pump (ABCB11). Mutations in ABCB4 and ABCB11 contribute to cholestatic diseases [e.g., progressive familial intrahepatic cholestasis 2 (PFIC2), PFIC3, and intrahepatic cholestasis of pregnancy], and our objective was to establish genetic variability and haplotype structures of ABCB4 and ABCB11 in healthy populations of different ethnic backgrounds. All coding exons, 5 of 6 noncoding exons, 50 to 300 base pairs of the flanking intronic regions, and 2.5 to 2.8 kilobase pairs of the promoter regions of ABCB4 and ABCB11 were sequenced in 159 and 196 DNA samples of Caucasian, African-American, Japanese, and Korean origin. In total, 76 and 86 polymorphisms were identified in ABCB4 and ABCB11, respectively; among them, 14 and 28 exonic polymorphisms, and 8 and 10 protein-altering variants, of which 4 were predicted to have functional consequences. Both genes showed substantial ethnic differences with respect to allele number, frequency of common and population-specific sites, and patterns of linkage disequilibrium. Population genetic analysis suggested some selective pressure against changes in the protein, supporting the important endogenous role of these transporters. Haplotype variability was greater in ABCB11 than in ABCB4. An ABCB11 promoter haplotype was associated with significant decrease of activity compared with wild type. Our results contribute to a better understanding of the molecular basis and of ethnic differences in drug response, and provide a valuable tool for future research on the heredity of cholestatic liver injury.
肝细胞中胆盐和其他胆汁成分的胆汁排泄由顶端(胆小管)转运蛋白P-糖蛋白3(MDR3,ABCB4)和胆盐输出泵(ABCB11)介导。ABCB4和ABCB11的突变会导致胆汁淤积性疾病[例如,进行性家族性肝内胆汁淤积症2型(PFIC2)、PFIC3和妊娠期肝内胆汁淤积症],我们的目标是确定不同种族背景健康人群中ABCB4和ABCB11的基因变异性和单倍型结构。对159份白种人、非裔美国人、日本人和韩国人来源的DNA样本以及196份同样来源的DNA样本进行测序,检测ABCB4和ABCB11的所有编码外显子、6个非编码外显子中的5个、侧翼内含子区域50至300个碱基对以及启动子区域2.5至2.8千碱基对。总共在ABCB4和ABCB11中分别鉴定出76个和86个多态性;其中,14个和28个外显子多态性,以及8个和10个蛋白质改变变体,其中4个预计具有功能后果。两个基因在等位基因数量、常见和群体特异性位点的频率以及连锁不平衡模式方面均表现出显著的种族差异。群体遗传分析表明存在针对蛋白质变化的一些选择压力,支持了这些转运蛋白重要的内源性作用。ABCB11的单倍型变异性大于ABCB4。与野生型相比,一种ABCB11启动子单倍型与活性显著降低相关。我们的结果有助于更好地理解药物反应的分子基础和种族差异,并为未来胆汁淤积性肝损伤遗传研究提供有价值的工具。